Effects of R(-)-1-(benzo[b]thiophen-5-yl)-2-[2-(N,N-diethylamino) ethoxy]ethanol hydrochloride (T-588), a novel cognitive enhancer, on noradrenaline release in rat cerebral cortical slices

Biochemical Pharmacology

Volumn 53, Issue 9, 1997, Pages 1263-1269

  Miyazaki, Hiroyuki ^a,b   Murayama, Toshihiko ^a   Satoshi, Ono ^b   Narita, Hirokazu ^b   Nomura, Yasuyuki ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

Ca2+ calmodulin; Cerebral cortical slices; N ethylmaleimide; Noradrenaline release; T 588

Indexed keywords

1 (BENZO[B]THIEN 5 YL) 2 (2 DIETHYLAMINOETHOXY)ETHANOL; 1 (BENZO[B]THIOPHEN 5 YL) 2 [2 (N,N DIETHYLAMINO)ETHOXYETHANOL; N ETHYLMALEIMIDE; NAPHTHALENESULFONIC ACID DERIVATIVE; NOOTROPIC AGENT; NORADRENALIN; PROTEIN KINASE (CALCIUM,CALMODULIN); TRIFLUOPERAZINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CALCIUM TRANSPORT; COGNITIVE DEFECT; DRUG EFFECT; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT;

ANIMALS; CALCIUM CHLORIDE; CENTRAL NERVOUS SYSTEM STIMULANTS; CEREBRAL CORTEX; DIETHYLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYLMALEIMIDE; MALE; NOREPINEPHRINE; RATS; RATS, WISTAR; THIOPHENES;

EID: 0030746697     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00020-8     Document Type: Article

References (33)

1. Ono S, Yamafuji T, Chaki H, Maekawa M, Kitamura K, Hirata K, Nakada Y, Hayakawa H, Hiraiwa T and Narita H, Effects of T-588, a novel cognitive enhancer, on various amnesia models in rodents. Soc Neurosci Abstr 20: 1234, 1993.
2. Ono S, Maekawa M, Miyazaki H, Kimura T, Nakada Y, Kurimoto H, Kozasa C, Hoki S, Ukai W, Hiraiwa T and Narita H, Effects of T-588, a newly synthesized cognitive enhancer, on the central nervous system. Soc Neurosci Abstr 20: 152, 1994.
3. Ono S, Yamafuji T, Chaki H, Todo Y, Maekawa M, Kitamura K, Kimura T, Nakada Y, Mozumi K and Narita H, A new cognition-enhancing agent, (R)-(-)-1-(benzo[b]thiophen-5-yl)-2-[2-(N,N-diethylamino)ethoxy]ethanol hydrochloride. Effects on memory impairment in rats generated by cerebral embolization and basal forebrain lesions. Biol Pharm Bull 18: 1779-1783, 1995.
4. Ono S, Kitamura K, Maekawa M, Hirata K, Ano M, Ukai W, Yamafuji T and Narita H, Protective effect of R(-)-1-(benzo[b]thiopen-5-yl)-2-[2-(N,N-diethylamino)ethoxy] ethanol hydrochloride (T-588), a novel cerebral activator, against experimental cerebral anoxia. Jpn J Pharmacol 62: 81-86, 1993.
5. Giovannini MG, Spignoli G, Carla V and Pepeu G, A decrease in brain catecholamines prevents oxiracetam antagonism of the effects of scopolamine on memory and brain acetylcholine. Pharmacol Res 24: 395-405, 1991.
6. Lee K and Sekine A, Effects of hypoxia on stimulus-release coupling mechanisms in cultured bovine adrenal chromaffin cells. Naunyn Schmiedebergs Arch Pharmacol 348: 275-281, 1993.
7. Seyfarth M, Feng Y, Hagl S, Sebening F, Richardt G and Schömig A, Effect of myocardial ischemia on stimulation-evoked noradrenaline release. Modulated neurotransmission m rat, guinea pig, and human cardiac tissue. Circ Res 73: 496-502, 1993.
8. O'Neill CM, Ball SG and Vaughan PFT, Effects of ischaemic conditions on uptake of glutamate, aspartate, and noradrenaline by cell lines derived from the human nervous system. J Neurochem 63: 603-611, 1994.
9. Moran PM, LeMaitre MH, Philouze V, Reymann JM, Allain H and Leonard BE, Reversal of learning and memory impairments following lesion of the nucleus basalis magnocellularis (NBM) by concurrent noradrenergic depletion using DSP4 in the rat. Brain Res 595: 327-333, 1992.
10. Stancheva S, Papazova M, Alova L and Lazarova-Bakarova M, Impairment of learning and memory in shuttle box-trained rats neonatally injected with 6-hydroxydopamine. Effects of nootropic drugs. Acta Physiol Pharmacol Bulg 19: 77-82, 1993.
11. Marighetto A, Jaffard R and Micheau J, Effects of intraseptally injected noradrenergic drugs on hippocampal sodium-dependent-high-affinity-choline-uptake in 'resting' and 'trained' mice. Brain Res 652: 120-128, 1994.
12. Ono S, Maekawa M, Kimura T, Takagi A, Nakamura A, Kondo K, Miyazaki H, Mozumi K, Matsui N and Narita H, Effects of T-588, a novel cognitive enhancer, on acetylcholine and monoamine releases and second messenger systems in rats. Soc Neurosci Abstr 21: 947, 1995.
13. 3H]clonidine binding in the rat brain cortex. Dev Neurosci 5: 198-204, 1982.
14. 2-adrenergic agonists. J Neurochem 56: 1387-1393, 1991.
15. 3H]noradrenaline release from chick sympathetic neurons: Role of cyclic AMP. J Neurochem 63: 146-154, 1994.
16. 3H]norepinephrine release by activation of alpha-2 adrenergic receptors in cultured rat ganglion cells. Neuroscience 52: 107-113, 1993.
17. Summers WK, Majovski LV, Marsh GM, Tachiki K and Kling A, Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 315: 1241-1245, 1986.
18. Ohno M, Yamamoto T and Watanabe S, Involvement of cholinergic mechanisms in impairment of working memory in rats following basolateral amygdaloid lesions. Neuropharmacology 31: 915-922, 1992.
19. Hodges H, Ribeiro AM, Gray JA and Marchbanks RM, Low dose tetrahydroaminoacridine (THA) improves cognitive function but does not affect brain acetylcholine in rats. Pharmacol Biochem Behav 36: 291-298, 1990.
20. Kawashima K, Sato A, Yoshizawa M, Fujii T, Fujimoto K and Suzuki T, Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats. Naunyn Schmiedebergs Arch Pharmacol 350: 523-528, 1994.
21. Baldwin HA, DeSouza RJ, Sarna GS, Murray TK, Green AR and Cross AJ, Measurements of tacrine and monoamines in brain by in vivo microdialysis argue against release of monoamines by tacrine at therapeutic doses. Br J Pharmacol 103: 1946-1950, 1991.
22. Arnsten AF and Goldman-Rakic PS, Noradrenergic mechanisms in age-related cognitive decline. J Neural Transm Suppl 24: 317-324, 1987.
23. Terbush DR and Holz RW, Activation of protein kinase C is not required for exocytosis from bovine adrenal chromaffin cells. J Biol Chem 265: 21179-21184, 1990.
24. 3 cells. J Biol Chem 266: 1484-1490, 1991.
25. Irons CE, Sei CA, Hidaka H and Glembotski CC, Protein kinase C and calmodulin kinase are required for endothelin-stimulated atrial natriuretic factor secretion from primary atrial myocytes. J Biol Chem 267: 5211-5216, 1992.
26. Gadbut AP, Cash SM, Dagiantis WP, Cooper S and Weyhenmeyer JA, Release of angiotensin in response to ionic stimulation: A possible role for calmodulin in the secretory event. Brain Res Bull 28: 551-555, 1992.
27. Safayhi H, Kühn M, Koopmann I and Ammon HPT, CGS9343B and W7 (calmodulin antagonists) inhibit KCl-induced increase in cytosolic free calcium and insulin secretion of RINm5F cells. Naunyn Schmiedebergs Arch Pharmacol 339: 8-13, 1989.
28. Virgilio FD, Milani D, Leon A, Meldolesi J and Pozzan T, Voltage-dependent activation and inactivation of calcium channels in PC12 cells. J Biol Chem 262: 9189-9195, 1987.
29. Appell KC and Barefoot DS, Neurotransmitter release from bradykinin-stimulated PC12 cells. Biochem J 263: 11-18, 1989.
30. 2+-dependent secretion. J Biol Chem 267: 8396-8403, 1992.
31. 2-adrenoceptor-mediated effects on norepinephrine release in rat tail arteries. J Cardiovasc Pharmacol 19: 958-965, 1992.
32. 2+ channels. Neurosci Lett 146: 84-86, 1992.
33. 2+ releasing mechanism of rat liver nuclei. Mol Cell Biochem 131: 167-172, 1994.